期刊文献+

慢性阻塞性肺疾病患者血浆精氨酸加压素及心钠素的变化及临床意义

Plasma Arginine Vasopressin and Artrial Natriuretic Peptide in Patients with Chronic Obstructive Pulmonary Disease:Survey of Changes and Clinical Significance
下载PDF
导出
摘要 目的探讨慢性阻塞性肺疾病(COPD)患者急性加重期和稳定期血浆精氨酸加压素(AVP)及心钠素(ANP)的变化及临床意义。方法用放射免疫法测定40例COPD患者(COPD组)血浆AVP和ANP水平,并与动脉血氧分压(PaO2)进行相关分析;另选择35例健康人作为正常对照组。结果(1)COPD组急性加重期和稳定期血浆AVP、ANP水平与正常对照组比较差异有显著性意义(P<0.01);急性加重期血浆AVP、ANP水平与稳定期比较差异有显著性意义(P<0.01);急性加重期PaO2与稳定期比较差异有显著性意义(P<0.01);(2)COPD组急性加重期和稳定期血浆AVP均与ANP呈正相关(P<0.01);AVP及ANP与PaO2均呈负相关(P<0.01)。结论AVP和ANP均可能参与COPD的病理生理过程,并相互作用;检测血浆AVP和ANP水平对反映COPD严重程度和预后有一定的临床价值。 Objective To explore the changes and clinical significance of Arginine Vasopressin (AVP) and Artrial Natriuretie Peptide (ANP) in patients with chronic obstructive pulmonary disease (COPD) at both acute stage and stable stage. Methods The levels of plasma AVP. ANP of 40 patients with COPD ( COPD group) were measured with radioimmunoassay ( RIA), and correlation analysis with arterial oxygen pressure ( PaO2 ) was carried out. 35 healthy subjects was enrolled as the control group. Results ( 1 ) Plasma AVP and ANP levels of COPD group in both acute stage and stable stage were obviously higher than those of control group ( AVP.. (133.7±51.8), (55.2±22.2), (4.7±3.8) ngoL-1; ANP.. (626.7± 161.2), (300. 6 ± 125.8), (67.3 ±59. 0) ngoL - 1, all P 〈0. 001 ) ] ; there was significant difference in plasma AVP and ANP levels between patients in acute stage and those in stable stage ( P 〈 0. 001 ) , and significant difference was observed in PaO2 between them [ (50. 0 ± 13.9) vs (76. 3 ± 11.3 ) mmHg, P 〈 0. 001 ] ; (2) In COPD group, AVP correlated positively with ANP in both acute and stable stages ( acute stage : r = 0. 63, P 〈 0. 001 ; r = 0. 44, P 〈 0. 01 ) ; (3) Both AVP and ANP correlated negatively with PaO2 in acute and stable stage ( acute stage: r = - 0. 53, P 〈 0. 01 ; r = - 0. 50, P 〈 0. 01 ; stable stage: r = -0. 43, P 〈 0. 01 ; r = -0. 54, P 〈 0. 001 ). Conclusion Both AVP and ANP may participate in pathophysiologic process of COPD, and might affect each other. The detection of AVP or ANP levels is of a practical value in estimating the extent and prognosis of COPD.
出处 《中国全科医学》 CAS CSCD 2007年第24期2043-2045,共3页 Chinese General Practice
关键词 精氨酸加压素 心钠素 肺疾病 阻塞性 慢性 Arginine vasopressin Artrial natriuretie peptide Pulmonary disease, obstructive, chronic
  • 相关文献

参考文献11

  • 1郝伟欣.慢性阻塞性肺疾病[J].中国全科医学,2004,7(6):365-367. 被引量:34
  • 2Nakamura T, Funayama H, Yoshimura A, et al. Possible vascular role of increased plasma arginine vasopressin in congestive heart failure [J]. IntJ Cardiol, 2006, 106:191 -d95.
  • 3Miller M. Hyponatremia and arginine vasopressin dysregulation : mechanisms, clinical consequences, and management [ J ]. J Am Geriatr Soc, 2006, 54:345-353.
  • 4张少军,何山.肾上腺髓质素等与慢性肺源性心脏病、肺动脉高压的关系[J].中国全科医学,2004,7(10):698-699. 被引量:3
  • 5Tei S, Di Rosa I, Clarioni R, et al. Atrial natriuretic peptide (ANP) system in the lung of Rana esculenta [ J]. J Morphol, 2004, 260: 184 - 192.
  • 6Umemura S, Segawa Y, Ueoka H, et al. Serum level of arginine - vasopressin influences the prognosis of extensive - disease small - cell lung cancer [J]. J Cancer Res Clin Oncol, 2007, 133:519 -524.
  • 7Price JF, Towbin JA, Denfield SW, et al. Arginine vasopressin levels are elevated and correlate with functional status in infants and children with congestive heart failure [ J]. Circulation, 2004, 109:2550 - 2553.
  • 8侯宇虹,潘金兵,王书钧.慢性阻塞性肺疾病患者血浆心钠素、C型利尿利钠因子的变化及意义[J].中华老年医学杂志,2002,21(5):375-376. 被引量:3
  • 9崔红生,武维屏,王琦,张立山.提高慢性阻塞性肺疾病临床疗效的思路与方法[J].中国全科医学,2004,7(8):548-549. 被引量:4
  • 10Oliveira- Souza M, Musa -Aziz R, Malnic G, et al. Arginine vasopressin stimulates H ^+ - ATPase in MDCK ceils via V1 ( cell Ca^2+ ) and V2 (cAMP) receptors [J]. Am J Physiol Renal Physiol, 2004, 286 : F402 - F408.

二级参考文献34

  • 1王琦,武维屏,田秀英,张冰清,张永涛.肺胀病机及益气活血化痰法的运用[J].中国医药学报,1995,10(3):29-31. 被引量:16
  • 2王国干,刘汉英,杨婉宜,李建蓉,赵颜芬,戴华苹,赵一举,华毅,张洪玉,程克正,宋松,李守平,苏德银,樊朝美,孟宪强,何建国,袁定华,程显声.血流频谱法估测慢性肺疾病患者肺动脉压的研究[J].中华结核和呼吸杂志,1996,19(5):290-293. 被引量:16
  • 3中华医学会呼吸病学分会.慢性阻塞性肺疾病(COPD)诊治规范[J].中华结核和呼吸杂志,1997,20:99-106.
  • 4Kakishita M,Nishikimi T,Okano Y,et al.Increased plasma levels of adrenomedullin in patients with pulmonary hypertension[J].Clin Sci Colch,1999,96(1):33-39
  • 5Martinez A,Miller MJ,Unsworth EJ,et al.Expression of adrenomedullin in normal human lung and in pulmonary tumors[J].Endocrinology,1995,136(9):4099-4105
  • 6全国肺心病协作组.慢性肺源性心脏病诊断标准[J].中华结核和呼吸系疾病杂志,1978,20(1):56-57.
  • 7王莉 王瑞兰.音乐疗法对COPD患者呼吸困难及焦虑症状的疗效研究[J].国外医学:护理学分册,2000,19(2):66-66.
  • 8Ohbayashi H,Yamaki K,Suzuki R,et al.Neutral endopeptidase 3.4.24.11 inhibition potentiates the inhibitory effects of type-C natriuretic peptide on leukotriene D4-induced airway change.Clin Exp Pharmacol Phsiol,1998,25:986-991.
  • 9Perreault T,Baribeau J, Gosselin R,et al.Reduced vasodilator response to ANF in hypoxia-induced pulmonary hypertension in the newborn piglet.Am J Physiol,1997,273:289-295.
  • 10慢性阻塞性肺疾病(COPD)诊治规范(草案)[J].中华结核和呼吸杂志,1997,20(4):199-203. 被引量:1381

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部